Palate Therapeutics
PrivateCompany Overview
Palate Therapeutics operates in Healthcare & Life Sciences and is based in Atlanta, Georgia. It was founded in 2022.
Palate Therapeutics is a biotechnology company that develops oral oligonucleotide-based therapies to modulate sweetness perception and metabolism for the management of metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Palate Therapeutics Comparables
Compare Palate Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EktaH | 82% | |
| Amaro Therapeutics, Inc. | 80% | |
| Biogen | 56% |
For institutional investors. Book with your work email.
Palate Therapeutics Funding Rounds
Historical fundraising activity
Palate Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Palate Therapeutics's valuation, stock price, and market status.
Is Palate Therapeutics a public or private company?
Palate Therapeutics is a private company.
What is the current stock price of Palate Therapeutics?
Palate Therapeutics is a private company, so its shares have no public market price. Caplight tracks Palate Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Palate Therapeutics worth (valuation)?
Valuation information for Palate Therapeutics is not publicly available.
Can I buy Palate Therapeutics stock?
Palate Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Palate Therapeutics's last funding round?
Funding round information for Palate Therapeutics is not publicly available.
Who are the main investors in Palate Therapeutics?
Investor information for Palate Therapeutics is not publicly disclosed.
Will Palate Therapeutics IPO soon?
No public IPO plans have been announced for Palate Therapeutics.
How can I track Palate Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Palate Therapeutics's shares on secondary markets.